Many Align Technology, Inc.(ALGN) Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock. Company shares were Reiterated by Stifel on Nov 28, 2016 to Buy, Raises Price Target to $ 110 from a previous price target of $95 .
Company has reported several Insider transactions to the SEC, on Feb 6, 2017, C Raymond Jr Larkin (director) sold 15,000 shares at 94.71 per share price.On Nov 29, 2016, Jennifer Olson (VP & Mgng Dir., D-DCC) sold 3,662 shares at 95.44 per share price.On Nov 29, 2016, Warren S Thaler (director) sold 8,500 shares at 95.57 per share price.
Align Technology Last issued its quarterly earnings results on Jan 31, 2017. The company reported $0.59 EPS for the quarter, missing the analyst consensus estimate by $ -0.07. Analyst had a consensus of $0.66. The company had revenue of $293.20 million for the quarter, compared to analysts expectations of $292.27 million. The companys revenue was up 27.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.60 EPS.
Align Technology, Inc. (NASDAQ:ALGN) has received a short term rating of hold from experts at Zacks with a rank of 3. The stock has been rated an average of 1.45 by 10 Brokerage Firm. 7 Wall Street Firms have rated the stock as a strong buys. 1 stock experts have also suggested a buy rating. 2 Brokerage Firms have advised hold.
Align Technology, Inc. (NASDAQ:ALGN) should head towards $108 per share according to 9 Analysts in consensus. However, if the road gets shaky, the stock may fall short to $99 per share. The higher price estimate target is at $120 according to the Analysts.
Align Technology, Inc. (NASDAQ:ALGN) rose 0.8% or 0.78 points on Tuesday and made its way into the gainers of the day. After trading began at $97.67 the stock was seen hitting $99.28 as a peak level and $97.31 as the lowest level. The stock ended up at $98.39. The daily volume was measured at 791,106 shares. The 52-week high of the share price is $102.1 and the 52-week low is $58.78. The company has a market cap of $7,841 million.
Align Technology Inc. designs, manufactures and markets the Invisalign System, a proprietary method for treating malocclusion. The System corrects malocclusion using a series of clear, removable appliances that gently move teeth to a desired final position. Because it does not rely on the use of metal or ceramic brackets and wires, the System significantly reduces the aesthetic and other limitations associated with braces. The Invisalign System also offers orthodontists a new means of carrying out their diagnosis and treatment planning processes.